Coproporphyrin I is formed during the decarboxylation and oxidation steps that convert pentacarboxylporphyrins into downstream heme intermediates. It represents one of the two major urinary coproporphyrins (I and III) and provides valuable information about the efficiency of late-stage heme biosynthesis and porphyrin turnover.
Elevations in Coproporphyrin I can arise from impaired conversion of porphyrinogens, oxidative stress, liver dysfunction, or metabolic strain affecting mitochondrial and detoxification pathways. Toxic exposures—particularly arsenic and some organic solvents—may preferentially raise Coproporphyrin I, often altering the balance between Coproporphyrin I and Coproporphyrin III. Nutrient insufficiencies (such as vitamin B6, zinc, iron, or glycine), infections, inflammatory stress, and high oxidative load can also influence levels.
Coproporphyrin I is best interpreted alongside Coproporphyrin III and the I/III ratio, as these relationships help identify specific pathway disruptions and differentiate between metabolic, toxic, and hepatic influences.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.